SCHEMBL21395913

SCHEMBL21395913

N#Cc1ccc(-c2ccc3c4cc(-c5ccc(-c6cc7cccnc7c7ncccc67)cc5)ccc4n(-c4ccccc4)c3c2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FABP1 P07148 1/20 0.38
TDP2 O95551 1/20 0.34
PIK3CD O00329 1/20 0.34
PIK3CA P42336 1/20 0.34
ATM Q13315 3/20 0.33
PGR P06401 2/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
PTGER4 P35408 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
PDPK1 O15530 1/20 0.33
ABCG2 Q9UNQ0 1/20 0.33
CCR1 P32246 2/20 0.33
CCR8 P51685 2/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
PDE4A P27815 2/20 0.32
PDE4C Q08493 2/20 0.32
PDE4D Q08499 2/20 0.32
PDE4B Q07343 1/20 0.32
CHEK1 O14757 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21396160 0.96 FABP1 (0.40) FABP1TDP2PIK3CDPIK3CAATM
SCHEMBL21395915 0.94 FABP1 (0.38) FABP1TDP2PIK3CDPIK3CAATM
SCHEMBL21395914 0.94 PDE4D (0.40) FABP1ABCG2PDE4APDE4CPDE4D
SCHEMBL21395917 0.88 PARP1 (0.42) FABP1TDP2PIK3CDPIK3CAPGR
SCHEMBL16520864 0.85 TDP2 (0.36) FABP1TDP2ATMPGRMEN1
SCHEMBL16456283 0.84 TDP2 (0.37) FABP1TDP2ATMPTGER4SMN1; SMN2
SCHEMBL15248256 0.82 ATM (0.49) PIK3CDPIK3CAATMPGRMEN1
SCHEMBL15250595 0.82 ATM (0.49) PIK3CDPIK3CAATMPGRMEN1
SCHEMBL16558156 0.82 FABP1 (0.41) FABP1TDP2PGRMEN1KMT2A
SCHEMBL16561058 0.82 FABP1 (0.41) FABP1TDP2PIK3CDPIK3CAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190292169-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2019-09-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190292169-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME LAGE3, PPOX, SUN2 FABP1 4775/4885TDP2 1980/4885PIK3CD 4712/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.